212 related articles for article (PubMed ID: 29077041)
1. Thymosin α1 Interacts with Hyaluronic Acid Electrostatically by Its Terminal Sequence LKEKK.
Mandaliti W; Nepravishta R; Pica F; Vallebona PS; Garaci E; Paci M
Molecules; 2017 Oct; 22(11):. PubMed ID: 29077041
[TBL] [Abstract][Full Text] [Related]
2. Thymosin α1 inserts N terminus into model membranes assuming a helical conformation.
Nepravishta R; Mandaliti W; Eliseo T; Sinibaldi Vallebona P; Pica F; Garaci E; Paci M
Expert Opin Biol Ther; 2015; 15 Suppl 1():S71-81. PubMed ID: 25642593
[TBL] [Abstract][Full Text] [Related]
3. Thymosin α1 interacts with Galectin-1 modulating the β-galactosides affinity and inducing alteration in the biological activity.
Matteucci C; Nepravishta R; Argaw-Denboba A; Mandaliti W; Giovinazzo A; Petrone V; Balestrieri E; Sinibaldi-Vallebona P; Pica F; Paci M; Garaci E
Int Immunopharmacol; 2023 May; 118():110113. PubMed ID: 37028279
[TBL] [Abstract][Full Text] [Related]
4. Bioactivity and pharmacokinetics of two human serum albumin-thymosin alpha1-fusion proteins, rHSA-Talpha1 and rHSA-L-Talpha1, expressed in recombinant Pichia pastoris.
Chen JH; Zhang XG; Jiang YT; Yan LY; Tang L; Yin YW; Cheng DS; Chen J; Wang M
Cancer Immunol Immunother; 2010 Sep; 59(9):1335-45. PubMed ID: 20473755
[TBL] [Abstract][Full Text] [Related]
5. Thymosin α1 activates complement receptor-mediated phagocytosis in human monocyte-derived macrophages.
Serafino A; Pica F; Andreola F; Gaziano R; Moroni N; Moroni G; Zonfrillo M; Pierimarchi P; Sinibaldi-Vallebona P; Garaci E
J Innate Immun; 2014; 6(1):72-88. PubMed ID: 23797159
[TBL] [Abstract][Full Text] [Related]
6. Thymosin α1 Interacts with Exposed Phosphatidylserine in Membrane Models and in Cells and Uses Serum Albumin as a Carrier.
Mandaliti W; Nepravishta R; Sinibaldi Vallebona P; Pica F; Garaci E; Paci M
Biochemistry; 2016 Mar; 55(10):1462-72. PubMed ID: 26909491
[TBL] [Abstract][Full Text] [Related]
7. Generation of mature Nα-terminal acetylated thymosin α 1 by cleavage of recombinant prothymosin α.
Liu B; Gong X; Chang S; Sun P; Wu J
ScientificWorldJournal; 2013; 2013():387282. PubMed ID: 24288480
[TBL] [Abstract][Full Text] [Related]
8. Production of Nα-acetylated thymosin α1 in Escherichia coli.
Ren Y; Yao X; Dai H; Li S; Fang H; Chen H; Zhou C
Microb Cell Fact; 2011 Apr; 10():26. PubMed ID: 21513520
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification and characterization of a novel soluble human thymosin alpha1 concatemer exhibited a stronger stimulation on mice lymphocytes proliferation and higher anti-tumor activity.
Li W; Song L; Wu S; Xue X; Zhang L; He L; Han W; Wang Q; Ling R; Zhang W; Yan Z; Zhang Y
Int J Biol Sci; 2011; 7(5):618-28. PubMed ID: 21647330
[TBL] [Abstract][Full Text] [Related]
10. Effect of a C-end rule modification on antitumor activity of thymosin α1.
Wang F; Xu C; Peng R; Li B; Shen X; Zheng H; Lao X
Biochimie; 2018 Nov; 154():99-106. PubMed ID: 30096371
[TBL] [Abstract][Full Text] [Related]
11. A tumor-penetrating peptide modification enhances the antitumor activity of thymosin alpha 1.
Lao X; Liu M; Chen J; Zheng H
PLoS One; 2013; 8(8):e72242. PubMed ID: 23977262
[TBL] [Abstract][Full Text] [Related]
12. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein.
Yang B; Yang BL; Savani RC; Turley EA
EMBO J; 1994 Jan; 13(2):286-96. PubMed ID: 7508860
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44.
Masellis-Smith A; Belch AR; Mant MJ; Turley EA; Pilarski LM
Blood; 1996 Mar; 87(5):1891-9. PubMed ID: 8634437
[TBL] [Abstract][Full Text] [Related]
14. Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation.
Binsfeld M; Hannon M; Otjacques E; Humblet-Baron S; Baudoux E; Beguin Y; Baron F; Caers J
Cancer Immunol Immunother; 2015 Aug; 64(8):989-98. PubMed ID: 25971542
[TBL] [Abstract][Full Text] [Related]
15. Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application.
Tao N; Xu X; Ying Y; Hu S; Sun Q; Lv G; Gao J
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110771
[TBL] [Abstract][Full Text] [Related]
16. Thymalfasin for the treatment of chronic hepatitis B.
Chien RN; Liaw YF
Expert Rev Anti Infect Ther; 2004 Feb; 2(1):9-16. PubMed ID: 15482167
[TBL] [Abstract][Full Text] [Related]
17. Expression of thymosin alpha1 concatemer in transgenic tomato (Solanum lycopersicum) fruits.
Chen Y; Wang A; Zhao L; Shen G; Cui L; Tang K
Biotechnol Appl Biochem; 2009 Apr; 52(Pt 4):303-12. PubMed ID: 18752465
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory and enhanced antitumor activity of a modified thymosin α1 in melanoma and lung cancer.
Wang F; Li B; Fu P; Li Q; Zheng H; Lao X
Int J Pharm; 2018 Aug; 547(1-2):611-620. PubMed ID: 29933059
[TBL] [Abstract][Full Text] [Related]
19. Thymosin alpha1 is a time and dose-dependent antagonist of dexamethasone-induced apoptosis of murine thymocytes in vitro.
Baumann CA; Badamchian M; Goldstein AL
Int J Immunopharmacol; 2000 Dec; 22(12):1057-66. PubMed ID: 11137612
[TBL] [Abstract][Full Text] [Related]
20. Modulatory role of thymosin-alpha-1 in normal bone-marrow haematopoiesis and its effect on myelosuppression in T-cell lymphoma bearing mice.
Paul S; Sodhi A
Immunol Lett; 2002 Jul; 82(3):171-82. PubMed ID: 12036599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
